Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Monitoramento clínico remoto após pancreatectomia distal robótica (TOTEM)

12 de novembro de 2026 atualizado por: Stessel Björn, Jessa Hospital

Monitoramento clínico remoto após pancreatectomia distal robótica: um estudo piloto e viabilidade

This feasibility trial has three main objectives:

  • To investigate the impact of the transmural care pathway TOTeM on the Length of Stay (LOS) for patients undergoing robotic distal pancreatectomy.
  • To investigate the feasibility of the implementation of TOTeM for patients undergoing robotic distal pancreatic surgery, we will measure the recruitment rate by tracking the number of eligible patients who are approached for participation, the percentage who consent to join the study over a specified time period, and the adherence rate which describes how well participants follow the study protocol including the prescribed interventions or follow-up assessments.
  • Assessment of the potential changes in medical costs and outcomes for the purpose of performing a cost-effectiveness analysis from a hospital and patient perspective.

Visão geral do estudo

Status

Rescindido

Condições

Descrição detalhada

Due to fast progress and improvements in robotic surgery, minimally invasive procedures for complex surgery have become increasingly feasible for the vast majority of patients. Over recent years, minimally distal pancreatectomy (MDP) has become the preferred approach for distal pancreatectomy. This minimally invasive alternative offers less postoperative pain, better cosmetic outcomes, a quicker recovery, a shorter hospital stay, decreased morbidity, reduced intraoperative blood loss, and reduced health care costs. This shift in care models has enabled patients to return home more quickly after surgery, while their recovery continues to be closely monitored.

Hospitals are increasingly confronted with high bed occupancy rates and the need to use staff more efficiently. This has emphasized the importance of optimizing the length of stay for patients undergoing pancreatectomy, ensuring they can be discharged sooner without compromising their recovery. Early discharge from the hospital, combined with remote monitoring, offers a promising solution to these challenges. Thanks to advances in technology, patients can be monitored remotely after discharge by healthcare professionals allowing for early detection of potential complications and timely intervention, all while the patient recovers in the comfort of their own home. This approach also facilitates the effective implementation of transmurally coordinated care pathways (care delivered across different levels of the healthcare system), ensuring seamless communication and care transitions between hospital and home.

The TOTeM (Transmurale Opvolging met TeleMonitoring na chirurgie) project, supported by the Federale Overheidsdienst Volksgezondheid, Veiligheid van de Voedselketen en Leefmilieu, focuses on remote monitoring of patients with the help of wearable monitoring devices and a telemonitoring hub. Unlike the current approach where the patient is admitted to the intensive care unit (ICU) after surgery, patients will be immediately transferred to the ward. The patient is sent home after surgery as early as medically possible (as defined by reaching all of the time to be fit criteria), with qualitative and specialized follow-up in the home setting. The time to be fit criteria include: oral pain medication only, independent walking, oral intake, hemodynamically (90% of baseline blood pressure, heart rate in 90% of normal range) and respiratory (no need for extra oxygen) stable, and no drains or urinary catheters. After discharge, the patient is contacted by the telemonitoring hub through a daily videocall. Parameters are assessed up to three times a day. Follow-up via the mobile application and videocall is foreseen up to ten days postoperatively. The telemonitoring hub screens all input from the questionnaires completed by the patient as well as the parameters that are obtained via wearable monitoring devices. If necessary, the patient is contacted or an escalation protocol is triggered. The project aims to enable a faster recovery of patients in a familiar home environment and a more active role of the patient in their recovery process. For the hospital, the faster discharge offers the opportunity to optimize bed occupancy. On a societal level, the social cost of care may decrease.

This pilot and feasibility study focuses on the application of remote clinical monitoring following robotic distal pancreatectomy. By evaluating the feasibility and effect of the implementation of such a care model, this research aims to contribute to optimizing care for patients undergoing these complex procedures, while also alleviating pressure on hospital resources and staff.

Tipo de estudo

Intervencional

Inscrição (Real)

2

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Locais de estudo

    • Limburg
      • Hasselt, Limburg, Bélgica, 3500
        • Jessa Hospital

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

18 anos a 75 anos (Adulto, Adulto mais velho)

Aceita Voluntários Saudáveis

Não

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Inclusion Criteria:

  • 18-75 years old
  • Competent to provide informed consent
  • Fluent in Dutch
  • Cognitively capable of understanding and engaging with the study
  • Undergoing robotic distal pancreatectomy
  • Owing a smartphone or has a caregiver who can assist
  • Does not live alone
  • Have a valid national identification number

Exclusion Criteria:

  • Extended left pancreatectomy
  • Spleen-preserving procedure
  • Residing in a nursing home
  • Patients who are deemed unsuitable for the study by the physician based on clinical evaluation
  • Absence of informed consent or request to not participate in the study

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Cuidados de suporte
  • Alocação: N / D
  • Modelo Intervencional: Atribuição de grupo único
  • Mascaramento: Nenhum (rótulo aberto)

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: Remote clinical monitoring

The application of remote clinical monitoring after a distal robotic pancreatectomy

Patients after a distal pancreatectomy will be discharged faster from the hospital and will be remote monitored

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Length of stay in hospital
Prazo: during hospital stay, an average of 4 days

The primary outcome measurement for the TOTeM care pathway in patients undergoing robotic distal pancreatectomy is the length of stay, which is the total time measured from day of surgery to the day of hospital discharge

during hospital stay, an average of 4 days

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Evaluation of the recruitment rate
Prazo: during whole study period, an average of 1 year

The feasibility of this pilot study is assessed by means of the recruitment rate, defined by the number of eligible patients who are approached for participation and the percentage who consent to join the study over a specified time period. The recruitment rate is defined as excellent if 20 patients can be enrolled in this study in one year.

during whole study period, an average of 1 year
Evaluation of the adherence rate
Prazo: during whole study period, an average of 1 year

The feasibility of this pilot study is assessed by the adherence rate, which describes how well participants follow the study protocol including the prescribed interventions or follow-up assessments. The adherence rate is defined as excellent if ≥80% of the patients followed the study protocol including the prescribed interventions or follow-up assessments.

during whole study period, an average of 1 year
Evaluation of medical costs
Prazo: during study time of patient, an average of 3 months

Evaluation of the potential changes in medical costs for the hospital and for the individual patient

during study time of patient, an average of 3 months
Assessment of surgical fear
Prazo: At baseline

The short and long term surgical fear questionnaire will be evaluated at baseline, before the surgery. The short and long term questionnaire consist each of 4 questions, where 0 indicates no fear and 10 indicates extreme fear.

At baseline
Quality of Life: EQ5D Questionnaire
Prazo: at baseline (day of surgery), Day7, Day28, Month3

Questionnaire measuring patients' general health and quality of life: EQ5D = EuroQol-5 Dimensions: mobility, self-care, daily activities, pain/discomfort, anxiety/depression. A score of 0 represent a very low quality of life, where score of 1 represents the maximum score.

at baseline (day of surgery), Day7, Day28, Month3
Quality of Life: SF-36 Questionnaire
Prazo: at baseline, Day 7, Day 28, Month 3

This questionnaire contains 36 questions and 8 dimensions: physical functioning, physical limitations, mental functioning, emotional limitations, social functioning, pain, general health, vitality. Scores for each domain range from 0 to 100, with a higher score defining a more favorable health state.

at baseline, Day 7, Day 28, Month 3
Evaluation of the technology acceptance questionnaire
Prazo: baseline

Evaluation of the technology acceptance questionnaire, which contains 17 statements where patient can (completely) disagree, no opion or (completely) agree with.

baseline
Pain scores (numerical rating scales)
Prazo: 3 times per day for 10 days after the surgery

Evaluation of different pain scores (abdominal pain, lower abdominal pain, pain at wound stitch hole, shoulder pain and pain after eating). These are numerical rating scales with 0 having no pain at all and 10 having extreme pain.

3 times per day for 10 days after the surgery
Satisfaction of patients
Prazo: on day 10 after the surgery
  • Degree to which the patient is satisfied with the care pathway, felt safe during remote monitoring, and if they received sufficient information about the follow-up period.
  • Measured with Numeric Rating Scale (NRS), with 0 not satisfied at all and 10 extremely satisfied
on day 10 after the surgery
Evaluation of pain medication
Prazo: daily up to 10 days after surgery

Assessment of the number of pain medication taken every day after the surgery

daily up to 10 days after surgery
Evaluation of the acceptability of the remote care pathway
Prazo: on postoperative day 10

This wil be evaluated with a validated questionnaire containing 8 statements which the patient need to score as (completely) agree, no opinion or (completely) disagree

on postoperative day 10
Evaluation of study patients admitted to the ICU
Prazo: during study period, an average of 1 year

The number of patients admitted to the ICU after surgery will be assessed

during study period, an average of 1 year
Evaluation of unplanned medical consultations or visits
Prazo: during study period of the patient, an average of 3 months

Assessment of unplanned readmission rate and/or unscheduled home visits from a general practitioner or other medical doctor and/or emergency consultations

during study period of the patient, an average of 3 months
Evaluation of post-operative complicatons
Prazo: during study period of the patient, an average of 3 months

Assessment of post-operative complications associated with distal pancreatectomy

during study period of the patient, an average of 3 months
Evaluation of respiratory rate
Prazo: during 10 days after surgery

Assessment of the respiratory rate, defined in breaths per minute.

during 10 days after surgery
Evaluation of the Intervention Appropriateness Measure
Prazo: on postoperative day 10

This wil be evaluated with a validated questionnaire containing 8 statements which the patient need to score as (completely) agree, no opinion or (completely) disagree

on postoperative day 10
Evaluation of the Feasibility of Intervention Measure
Prazo: on postoperative day 10

This wil be evaluated with a validated questionnaire containing 8 statements which the patient need to score as (completely) agree, no opinion or (completely) disagree

on postoperative day 10
Evaluation of temperature
Prazo: during 10 days after surgery

Assessment of the temperature of the patient, defined in °C.

during 10 days after surgery
Evaluation of oxygen saturation in blood
Prazo: during 10 days after surgery

Assessment of oxygen saturation in blood, measured in %

during 10 days after surgery

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Patrocinador

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Real)

21 de outubro de 2025

Conclusão Primária (Real)

30 de setembro de 2026

Conclusão do estudo (Real)

30 de setembro de 2026

Datas de inscrição no estudo

Enviado pela primeira vez

27 de fevereiro de 2025

Enviado pela primeira vez que atendeu aos critérios de CQ

17 de março de 2025

Primeira postagem (Real)

18 de março de 2025

Atualizações de registro de estudo

Última Atualização Postada (Real)

16 de novembro de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

12 de novembro de 2026

Última verificação

1 de novembro de 2026

Mais Informações

Termos relacionados a este estudo

Outros números de identificação do estudo

  • 2025/012

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever